Insulin Glargine (U-100) Cartridge Systems and Pens and Ledipasvir and sofosbuvir
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Ledipasvir and sofosbuvir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ledipasvir / sofosbuvir
Brand name: Harvoni
Synonyms: Ledipasvir and Sofosbuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Ledipasvir and Sofosbuvir Tablets
- Insulin Glargine (U-100) Cartridge Systems and Pens-Leena
- Insulin Glargine (U-100) Cartridge Systems and Pens-Lefamulin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Lefamulin Acetate
- Insulin Glargine (U-100) Cartridge Systems and Pens-Lefamulin Injection
- Insulin Glargine (U-100) Cartridge Systems and Pens-Lefamulin Tablets
- Ledipasvir and sofosbuvir-Insulin Glargine (U-100) Vials
- Ledipasvir and sofosbuvir-Insulin Glargine (U-300) Pens
- Ledipasvir and sofosbuvir-Insulin glargine and lixisenatide
- Ledipasvir and sofosbuvir-Insulin glargine and lixisenatide Subcutaneous
- Ledipasvir and sofosbuvir-Insulin glargine, recombinant Subcutaneous
- Ledipasvir and sofosbuvir-Insulin glulisine